As digital health technologies continue to advance, the healthcare industry is transforming at a rapid pace. Artificial intelligence (AI) and machine learning (ML) are two of the most promising technologies that have the potential to revolutionize healthcare. These technologies can help speed up the development of new medical products, including both pharmaceuticals and medical devices.
In response to the growing use of these technologies in healthcare, regulatory bodies such as the US Food and Drug Administration (FDA) are actively updating their policies to keep up with the changing landscape. This webinar will explore how the FDA regulates digital health technologies, particularly AI/ML, that are used for health-related purposes.
We will also cover recent FDA developments related to AI/ML and discuss the FDA’s policies around the use of these technologies in pharmaceutical and medical device research and development activities. Participants from various states can receive CLE credit for attending this webinar, including California, Illinois, New York, Pennsylvania, Texas, Virginia, and Washington. Additionally, those from Connecticut, Florida, and New Jersey can receive CLE credit through reciprocity.
Join us to gain valuable insights into the FDA’s approach to regulating digital health technologies and stay informed about the latest developments in this rapidly evolving field.